Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction.

Clinical Ophthalmology
Ester CarreñoJosé M Herreras

Abstract

Ophthalmic bromfenac sodium sesquihydrate is a topically applied selective cyclooxygenase (COX)-2 inhibitor. It is similar to amfenac, except for a bromine atom at the C(4) of the benzoyl ring position, which markedly affects its in vitro and in vivo potency, extends the duration of anti-inflammatory activity, and enhances its inhibitory effect on COX-2 absorption across the cornea and penetration into ocular tissues. The United States Food and Drug Administration approved bromfenac in 2005 for the treatment of postoperative inflammation and the reduction of ocular pain in patients who have undergone cataract surgery. Nonsteroidal anti-inflammatory drugs (NSAIDs), and among them bromfenac, could be even more effective than steroids at reestablishing the blood-aqueous barrier, as revealed by flare on slit-lamp examination and as quantitatively measured using ocular fluorophotometry. Similar to other NSAIDs, it has a role in inhibiting intraoperative miosis during cataract surgery. However, bromfenac also seems to be useful in other situations, such as refractive surgery, allergic conjunctivitis (not useful in dry eye), choroidal neovascularization, and even ocular oncology. No reports of systemic toxicity have been published and...Continue Reading

References

Jan 1, 1992·Survey of Ophthalmology·A J Flach
Jun 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M K O'BanionD A Young
Apr 1, 1995·Ophthalmology·M Sainz de la MazaN S Jabbur
Apr 1, 1993·Journal of Computer-aided Molecular Design·J RuizR Pouplana
Jan 1, 1996·Journal of Cataract and Refractive Surgery·C W Roberts
Aug 13, 1999·The American Journal of Gastroenterology·E B HunterJ A Awad
Nov 5, 1999·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·R J FontanaW M Lee
Dec 23, 2000·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·L MissottenC Trinquand
Jun 22, 2001·Klinische Monatsblätter für Augenheilkunde·Y Guex-Crosier
Sep 22, 2001·Journal of Cataract and Refractive Surgery·N HashizumeY Ohnishi
Oct 13, 2001·Circulation Research·S T Davidge
Aug 23, 2002·International Ophthalmology Clinics·Allan Joseph Flach
Jun 5, 2003·Journal of Cataract and Refractive Surgery·Victor E ReviglioTerrence P O'Brien
Jan 22, 2004·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Terumasa HashimotoShigekatsu Kohno
Feb 18, 2004·Current Cancer Drug Targets·Chinthalapally V Rao, Bandaru S Reddy
Apr 8, 2004·Clinical & Experimental Ophthalmology·Seung-Heon ChaChi-Dae Kim
Sep 17, 2004·Current Eye Research·Takayuki OkaMitsuyoshi Azuma
Dec 14, 2004·Japanese Journal of Ophthalmology·Minori Miyake-KashimaHiroshi Fujishima
Aug 26, 2006·Journal of Cataract and Refractive Surgery·Eric D DonnenfeldTimothy Chou
Oct 3, 2006·American Journal of Ophthalmology·João Pessoa Souza FilhoMiguel N Burnier
Mar 8, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Kaevalin LekhanontRoy S Chuck
Apr 19, 2007·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Eiichi UchioKazuaki Kadonosono
Aug 28, 2007·Journal of Cataract and Refractive Surgery·Hanny Isawi, Deepinder K Dhaliwal
Feb 23, 2008·Current Eye Research·Lorna M CryanColm O'Brien
Feb 27, 2008·Seminars in Immunopathology·Mrinali Patel, Chi-Chao Chan
Jul 31, 2008·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·George A BaklayanTimothy R McNamara
Aug 30, 2008·Journal of Cataract and Refractive Surgery·Frank A Bucci, L David Waterbury
Dec 4, 2008·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Kensaku MiyakeTimothy R McNamara
Feb 3, 2009·Acta Ophthalmologica·Masaru MiyanagaSatoshi Kato

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Survey of Ophthalmology
Stephen Jae KimLee M Jampol
Current Medical Research and Opinion
Steven M SilversteinBromfenac Ophthalmic Solution Once Daily (Bromday) Study Group
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
George A BaklayanTimothy R McNamara
© 2021 Meta ULC. All rights reserved